Samil Pharm (000520) — Free Cash Flow Generation Index
Samil Pharm (000520) has a Free Cash Flow Generation Index of -0.33x as of June 2025. Free cash flow of ₩-814.57 Million represents 0% of operating cash flow (₩2.44 Billion). See Samil Pharm short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Samil Pharm Free Cash Flow Generation Index (2012–2024)
Historical FCF Generation Index trend for Samil Pharm across 10 annual periods. Explore cash flow to debt ratio of Samil Pharm to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Samil Pharm (2012–2024)
Year-by-year Free Cash Flow Generation Index for Samil Pharm. For the full company profile including market capitalisation, see Samil Pharm market capitalisation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.17x | ₩-3.02 Billion | ₩2.59 Billion | ₩5.61 Billion | ▼ -8.4% |
| 2023 | -1.08x | ₩-12.65 Billion | ₩11.75 Billion | ₩24.39 Billion | ▲ +90.0% |
| 2022 | -10.71x | ₩-44.50 Billion | ₩4.15 Billion | ₩48.48 Billion | ▲ +52.1% |
| 2021 | -22.35x | ₩-31.67 Billion | ₩1.42 Billion | ₩32.83 Billion | ▼ -1741.9% |
| 2020 | -1.21x | ₩-9.44 Billion | ₩7.77 Billion | ₩17.02 Billion | ▼ -230.4% |
| 2019 | -0.37x | ₩-3.89 Billion | ₩10.59 Billion | ₩13.89 Billion | ▲ +96.5% |
| 2017 | -10.43x | ₩-39.55 Billion | ₩3.79 Billion | ₩36.33 Billion | ▼ -682.6% |
| 2016 | 1.79x | ₩10.09 Billion | ₩5.63 Billion | ₩4.45 Billion | ▼ -0.9% |
| 2015 | 1.81x | ₩5.28 Billion | ₩2.92 Billion | ₩2.36 Billion | ▲ +31.0% |
| 2012 | 1.38x | ₩6.93 Billion | ₩5.02 Billion | ₩1.91 Billion | — |